Active Implantable Medical Device For Cardiac Resynchronization With Automatic Optimization Of Atrioventricular And Interventricular Delays

• US 20110093027A1
• Filed: 10/18/2010
• Published: 04/21/2011
• Est. Priority Date: 10/19/2009
• Status: Active Grant

• Current Assignee: Sorin CRM USA (MicroPort Scientific Corp.)
• Original Assignee: Sorin CRM USA (MicroPort Scientific Corp.)
• Inventors: CASSET, Cyrille, RENESTO, Fabrizio
• Granted Patent: US 8,219,193 B2
• Time in Patent Office: Days
• US Class Current: 607/9
• CPC Class Codes: A61B 5/1107 Measuring contraction of parts of the body, e.g. organ, muscle apparatus for measuring work or force in general G01L
• CPC Class Codes: A61B 5/364 Detecting abnormal ECG interval, e.g. extrasystoles, ectopic heartbeats
• CPC Class Codes: A61B 5/6869 Heart
• CPC Class Codes: A61N 1/36578 controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/3682 with a variable atrioventricular delay
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation
• CPC Class Codes: A61N 1/37264 Changing the program; Upgrading firmware

Abstract

An active implantable medical device for cardiac resynchronization with automatic optimization of atrioventricular and interventricular delays is disclosed. The device collects an endocardial acceleration signal EA and calculates the atrioventricular delay AVD and the interventricular delay VVD. The device isolate in the EA signal a component EA4 corresponding to the fourth EA peak and measure a temporal parameter related to a time interval between the detection of an atrial event (P/A) and the occurrence of the EA4 component. The device isolates an EA1 component corresponding to the first EA peak and measures a non-temporal parameter (A_PEA1) related to the peak amplitude or a signal energy of the EA1 component. The optimal AVD (AVDO) is determined by the temporal parameter related to the EA4 component, and is calculated for a plurality of different values of VVD to obtain a plurality of pairs of optimal values {AVDO, VVD}. The device selects one of these pairs of values based on the non-temporal parameter related to the EA1 component.

Claims

1. An active implantable medical device for cardiac resynchronization therapy, comprising:

means for detecting spontaneous and stimulated atrial events and spontaneous and stimulated ventricular events;

means for stimulating a patient'"'"'s left and right ventricles;

means for calculating of an atrioventricular delay (AVD) having a duration counted from a detection of one of a spontaneous and stimulated atrial event;

means for delivering a ventricle stimulation pulse in the right ventricle in the absence of detected spontaneous ventricular event during the calculated AVD;

means for calculating an inter-ventricular delay (VVD) between delivery of stimulation pulses in the patient'"'"'s left and right ventricles; and

means for collecting of an endocardial acceleration (EA) signal representative of movements produced by cyclical contractions of the patient'"'"'s atrial and ventricular cavities;

wherein the means for calculating the AVD and the means for calculating the VVD further comprise;

means for identifying and isolating in the collected EA signal a component EA4 that corresponds to the fourth peak of the EA signal associated with the atrial activity, and a first measure of a temporal parameter related to the time interval between the atrial event detection (P/A) and a marker related to the EA4 component that immediately follows the atrial event detection;

means for identifying and isolating in the EA signal a component EA1 that corresponds to the first peak of endocardial acceleration associated with the ventricular isovolumetric contraction, and a second measure of one of a non-temporal parameter related to the peak amplitude or a signal energy of the EA1 component;

means for determining an optimal AVD (AVDO) as a function of said first measure, said AVDO being calculated for each of a plurality of different values of VVD, so as to obtain a plurality of pairs of values {AVDO, VVD} and

means for selecting, among said plurality of pairs of values {AVDO, VVD}, one of said pairs of values based on said non-temporal parameter related to the EA1 component.

2. The device of claim 1, wherein the means for selecting one of said pairs of values {AVDO, VVD} further comprises means for selecting said pair of values that maximizes the second measure.

3. The device of claim 1, wherein the means for determining the AVDO further comprises means for calculating the AVDO from said first measure, increased by a delay compensation constant.

4. The device of claim 1, wherein said marker linked to the EA4 component is a marker of a moment of occurrence of the fourth peak of endocardial acceleration.

5. The device of claim 1, wherein said marker linked to the EA4 component is a marker of one of a start time and an end time of the EA4 component.

6. The device of claim 1, wherein said means for determining said AVDO further comprises, for each value of said plurality of different values of VVD, over a first cardiac cycle:

means for selecting at least one predetermined AVD value;

means for measuring said temporal parameter related to the EA4 component as said first measure;

determining a corresponding AVDO value as a function of said first measure;

over an immediately following cardiac cycle;

means for selecting a value corresponding to the AVDO value determined in the previous cycle; and

means for measuring said one parameter related to the non-temporal EA1 component as said second measure.

7. The device of claim 6, wherein said predetermined AVD value is selected to be long enough to detect a consecutive spontaneous ventricular depolarization.

8. The device of claim 6, wherein a plurality of predetermined AVD values are selected during successive cardiac cycles, and the temporal parameter related to the EA4 component is measured with an AVD value for which the EA4 component is recognized and isolated.